Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

Insulin: The Receptor and Signaling Pathways

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

Hormones Regulating Blood Glucose

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

Oral Hypoglycemic Agents: Glinides

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

GPR40 agonists for the treatment of type 2 diabetes: life after 'TAKing' a hit.

Diabetes, obesity & metabolism·2015

Same author

Lipotoxicity impairs incretin signalling.

Diabetologia·2012

Same author

G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1.

Diabetologia·2012

Same author

Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass.

Diabetologia·2010

Same author

Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.

Diabetologia·2009

Same author

[2006 Apollinaire Bouchardat Award. Fatty acids and pancreatic beta cell function].

Journees annuelles de diabetologie de l'Hotel-Dieu·2006

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Lipid receptors and islet function: therapeutic implications?

M A Kebede¹, T Alquier, M G Latour

¹Montréal Diabetes Research Center, CRCHUM, QC, Canada.

Diabetes, Obesity & Metabolism

|October 13, 2009

Summary

This summary is machine-generated.

Lipid-activated G-protein coupled receptors (GPCRs) like GPR40, GPR119, GPR120, GPR41, and GPR43 play roles in insulin secretion and type 2 diabetes treatment. Further research is needed to clarify their mechanisms and therapeutic potential.

More Related Videos

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Published on: June 25, 2012

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Published on: May 14, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets

Published on: June 25, 2012

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates

Published on: May 14, 2019

Area of Science:

Endocrinology
Pharmacology
Molecular Biology

Background:

G-protein coupled receptors (GPCRs) are crucial drug targets, with several lipid-activated GPCRs identified in pancreatic beta-cells.
These receptors, including GPR40, GPR119, GPR120, GPR41, and GPR43, are implicated in regulating insulin secretion and glucose homeostasis.

Purpose of the Study:

To review the roles of lipid-activated GPCRs in pancreatic beta-cell function and their potential as therapeutic targets for type 2 diabetes.
To highlight the current understanding and remaining questions regarding the mechanisms and physiological significance of these receptors.

Main Methods:

Literature review and synthesis of existing research on lipid-activated GPCRs.
Analysis of data concerning the activation, expression, and functional effects of GPR40, GPR119, GPR120, GPR41, and GPR43.

Main Results:

GPR40 activation by fatty acids amplifies glucose-induced insulin secretion, suggesting agonism as a potential diabetes therapy.
GPR119 enhances insulin levels via direct action on beta-cells and GLP-1 secretion.
GPR120, GPR41, and GPR43 are involved in fatty acid-mediated GLP-1 release and indirect regulation of beta-cell function through adipokines.

Conclusions:

Lipid-activated GPCRs represent promising targets for type 2 diabetes drug development.
Further investigation is required to fully elucidate the complex mechanisms of action and physiological roles of these receptors.